ICA-3001

N/A

Report date: 2023/09/06 17:59:21

Base Information

Drug NameICA-3001
Drug Alias NameICA-3001ICA3001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesSuzhou Aika Liyuan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Aika Liyuan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A